Year |
Citation |
Score |
2020 |
Tivey TR, Parkinson JE, Weis VM. Host and Symbiont Cell Cycle Coordination Is Mediated by Symbiotic State, Nutrition, and Partner Identity in a Model Cnidarian-Dinoflagellate Symbiosis. Mbio. 11. PMID 32156819 DOI: 10.1128/Mbio.02626-19 |
0.535 |
|
2020 |
Tivey TR, Parkinson JE, Mandelare PE, Adpressa DA, Peng W, Dong X, Mechref Y, Weis VM, Loesgen S. N-Linked Surface Glycan Biosynthesis, Composition, Inhibition, and Function in Cnidarian-Dinoflagellate Symbiosis. Microbial Ecology. PMID 31982929 DOI: 10.1007/S00248-020-01487-9 |
0.523 |
|
2018 |
Layer JV, Cleary JP, Brown AJ, Stevenson KE, Morrow SN, Van Scoyk A, Blasco RB, Karaca E, Meng FL, Frock RL, Tivey T, Kim S, Fuchs H, Chiarle R, Alt FW, et al. Parp3 promotes long-range end joining in murine cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 30213852 DOI: 10.1073/Pnas.1801591115 |
0.412 |
|
2018 |
Parkinson JE, Tivey TR, Mandelare PE, Adpressa DA, Loesgen S, Weis VM. Subtle Differences in Symbiont Cell Surface Glycan Profiles Do Not Explain Species-Specific Colonization Rates in a Model Cnidarian-Algal Symbiosis. Frontiers in Microbiology. 9: 842. PMID 29765363 DOI: 10.3389/Fmicb.2018.00842 |
0.533 |
|
2017 |
Day TA, Layer JV, Cleary JP, Guha S, Stevenson KE, Tivey T, Kim S, Schinzel AC, Izzo F, Doench J, Root DE, Hahn WC, Price BD, Weinstock DM. PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA. Nature Communications. 8: 15110. PMID 28447610 DOI: 10.1038/Ncomms15110 |
0.311 |
|
2016 |
Jacobson C, Kopp N, Layer JV, Redd RA, Tschuri S, Haebe S, van Bodegom D, Bird L, Christie AL, Christodoulou A, Saur A, Tivey T, Zapf S, Bararia D, Zimber-Strobl U, et al. HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma. Blood. PMID 27742706 DOI: 10.1182/Blood-2016-04-711176 |
0.361 |
|
2015 |
Wu SC, Li LS, Kopp N, Montero J, Chapuy B, Yoda A, Christie AL, Liu H, Christodoulou A, van Bodegom D, van der Zwet J, Layer JV, Tivey T, Lane AA, Ryan JA, et al. Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia. Cancer Cell. 28: 29-41. PMID 26175414 DOI: 10.1016/J.Ccell.2015.06.005 |
0.393 |
|
2015 |
Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, et al. Mutations in G protein β subunits promote transformation and kinase inhibitor resistance. Nature Medicine. 21: 71-5. PMID 25485910 DOI: 10.1038/Nm.3751 |
0.345 |
|
2014 |
Lane AA, Chapuy B, Lin CY, Tivey T, Li H, Townsend EC, van Bodegom D, Day TA, Wu SC, Liu H, Yoda A, Alexe G, Schinzel AC, Sullivan TJ, Malinge S, et al. Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Nature Genetics. 46: 618-23. PMID 24747640 DOI: 10.1038/Ng.2949 |
0.409 |
|
2014 |
Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu S, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, et al. GNB1 Activating Mutations Promote Myeloid and Lymphoid Neoplasms Targetable By Combined PI3K/mTOR Inhibition Blood. 124: 3567-3567. DOI: 10.1182/Blood.V124.21.3567.3567 |
0.436 |
|
2014 |
Kopp N, Tschuri S, Haebe S, Bodegom Dv, Bird L, Christie AL, Saur A, Christodoulou AN, Tivey T, Kung AL, Weigert O, Weinstock D. Newer-Generation HSP90 Inhibitors Can Overcome Ibrutinib Resistance and Suppress Proliferation in Human Mantle Cell Lymphoma in Vitro and in Vivo Blood. 124: 1686-1686. DOI: 10.1182/Blood.V124.21.1686.1686 |
0.385 |
|
2014 |
Lane AA, Chapuy B, Lin CY, Tivey T, Li H, Townsend E, Bodegom Dv, Day TA, Wu S, Liu H, Yoda A, Alexe G, Schinzel A, Sullivan TJ, Malinge S, et al. Abstract 433: Triplication of HMGN1 promotes B cell acute lymphoblastic leukemia (B-ALL) through suppression of H3K27me3 Cancer Research. 74: 433-433. DOI: 10.1158/1538-7445.Am2014-433 |
0.424 |
|
2013 |
Yoda A, Adelmant G, Shindoh N, Chapuy B, Yoda Y, Weigert O, Kopp N, Wu S, Kim SS, Liu H, Tivey T, Tyner JW, Gotlib J, Deininger MW, Turley S, et al. The Beta-Subunit Of Heterotrimeric G Proteins Harbors Gain-Of-Function Mutations In Multiple Hematologic Malignancies Blood. 122: 2510-2510. DOI: 10.1182/Blood.V122.21.2510.2510 |
0.454 |
|
2013 |
Yoda A, Adelmant G, Shindoh N, Chapuy B, Yoda Y, Weigert O, Kopp N, Wu S, Kim SS, Liu H, Tivey T, Tyner JW, Gotlib J, Deininger MW, Turley S, et al. Abstract PR07: Novel oncogenic mutations in the beta subunit of heteromeric G-proteins identified by functional cDNA library screening. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-Pr07 |
0.41 |
|
2012 |
Greenblatt MB, Vrbanac V, Vbranac V, Tivey T, Tsang K, Tager AM, Aliprantis AO. Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. Plos One. 7: e44664. PMID 22957096 DOI: 10.1371/Journal.Pone.0044664 |
0.327 |
|
2012 |
Weigert O, Bodegom Dv, Bird L, Saur A, Tivey T, Kopp N, Kung AL, Weinstock D. Newer-Generation HSP90 Inhibitors Have Potent Activity Against Human Mantle Cell Lymphoma in Vitro and in Vivo Blood. 120: 1651-1651. DOI: 10.1182/Blood.V120.21.1651.1651 |
0.36 |
|
2012 |
Lane AA, van Bodegom D, Chapuy B, Alexe G, Sullivan TJ, Tivey T, Day T, Crispino J, Fox E, Stegmaier K, Weinstock D. Trisomy of the Down Syndrome Critical Region Suppresses Precursor B-Cell Differentiation and Promotes B-Cell Transformation Associated with Altered Expression of Polycomb Repressor Complex 2 Targets Blood. 120: 115-115. DOI: 10.1182/Blood.V120.21.115.115 |
0.458 |
|
Show low-probability matches. |